凯美特气(002549) - 2023 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2023 was ¥139,404,388.57, a decrease of 30.77% compared to ¥201,358,482.62 in the same period last year[4] - The net profit attributable to shareholders was a loss of ¥8,925,036.13, representing a decline of 115.86% from a profit of ¥56,285,249.11 in the previous year[4] - The total operating revenue for Q1 2023 was CNY 139,404,388.57, a decrease of 30.7% compared to CNY 201,358,482.62 in the same period last year[23] - The total operating costs for Q1 2023 were CNY 159,393,021.38, an increase of 11.1% from CNY 143,437,550.43 in Q1 2022[23] - The net profit for the first quarter of 2023 was -9,033,521.40 CNY, a significant decrease compared to a net profit of 57,090,548.74 CNY in the same period last year, representing a decline of approximately 115.8%[24] - Operating profit for the first quarter was -12,543,481.26 CNY, compared to an operating profit of 63,044,392.20 CNY in the previous year, indicating a decline of around 119.9%[24] - The total comprehensive income for the first quarter was -9,033,521.40 CNY, down from 57,090,548.74 CNY, reflecting a decrease of approximately 115.8%[25] - The basic and diluted earnings per share for the first quarter were both -0.0143 CNY, compared to 0.0902 CNY in the previous year, reflecting a decline of approximately 115.8%[25] Cash Flow - The net cash flow from operating activities increased by 150.85% to ¥88,137,698.54, up from ¥35,135,438.14 year-on-year[4] - Cash flow from operating activities generated a net inflow of 88,137,698.54 CNY, compared to 35,135,438.14 CNY in the previous year, marking an increase of about 151.5%[26] - The net cash flow from investing activities was -242.58 million RMB, an increase of 226.39% compared to the same period last year, primarily due to an increase in cash received related to investment activities by 76.15 million RMB[14] - Cash flow from investing activities resulted in a net outflow of -242,575,143.57 CNY, worsening from -74,320,950.26 CNY year-over-year[26] - The net cash flow from financing activities was 91.01 million RMB, an increase of 42.80% from the previous period, mainly due to cash received from employee stock incentive payments of 31.12 million RMB and an increase in cash received from borrowings by 80.00 million RMB[14] - Cash flow from financing activities showed a net inflow of 91,009,444.78 CNY, compared to 63,731,683.64 CNY in the previous year, indicating an increase of approximately 42.7%[26] Assets and Liabilities - The total assets at the end of the reporting period were ¥2,317,627,419.18, reflecting a growth of 3.64% from ¥2,236,259,984.30 at the end of the previous year[4] - The total assets as of March 31, 2023, were CNY 2,317,627,419.18, compared to CNY 2,236,259,984.30 at the start of the year, reflecting a growth of 3.6%[22] - The total liabilities increased to CNY 1,069,575,341.24 from CNY 998,731,968.32, marking a rise of 7.1%[23] - The company's short-term borrowings decreased to CNY 530,507,527.78 from CNY 580,518,986.12, a reduction of 8.6%[22] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 48,706, with no preferred shareholders[16] - The largest shareholder, Haoxun Technology Co., Ltd., holds 40.68% of the shares, amounting to 259,861,273 shares, with 100 million shares pledged[16] - The top ten shareholders include several state-owned entities, indicating a strong institutional presence in the company's ownership structure[17] Investment and Projects - The company plans to issue shares to specific targets, with a total amount not exceeding 1 billion RMB, to invest in various projects including a special gas project in Yizhang with an investment of 585.75 million RMB[18] - The company intends to invest 430 million RMB in a high-purity food-grade and electronic-grade hydrogen peroxide project with a total investment of 517.83 million RMB[18] - The company received approval from the Shenzhen Stock Exchange for its application to issue shares to specific targets, pending approval from the China Securities Regulatory Commission[18] - The company reported a significant increase in cash outflows related to investment activities, highlighting a strategic focus on expansion and development[14] - The company is actively pursuing financing strategies to support its growth initiatives, as evidenced by the increase in cash flow from financing activities[14] Operational Metrics - The company's cash and cash equivalents at the end of Q1 2023 amounted to CNY 807,376,728.35, slightly up from CNY 802,225,711.61 at the beginning of the year[21] - The company's cash and cash equivalents at the end of the period were 513,953,066.06 CNY, down from 577,445,062.02 CNY at the beginning of the period, a decrease of about 11.0%[26] - The company's R&D expenses for Q1 2023 were CNY 10,496,304.06, slightly down from CNY 11,673,592.54 in the previous year[23] - The company did not report any new product launches or technological advancements during this quarter[27] Management and Expenses - Management expenses increased by 53.72% to ¥27,968,900.00, largely due to new equity incentive expenses of ¥9,630,000.00[12] - The company experienced a 427.41% increase in fair value changes, reaching ¥991,000.00 compared to ¥187,900.00 in the previous year[12] - The net profit from asset disposals increased by 438.90% to ¥139,600.00 from ¥25,900.00 year-on-year, indicating improved asset management[12] - The company granted 3.8 million restricted stocks at a price of CNY 8.19 per share to 76 incentive recipients on March 9, 2023[19] - The company signed a framework agreement with China National Petroleum Corporation for the supply of hydrogen gas, ensuring stable supply under agreed quality and quantity conditions[19]